lactic acid has been researched along with ribosomal protein l7-l12 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, R; Goel, D; Singh, D | 1 |
| Aggarwal, S; Bhatnagar, R; Singh, D; Somani, VK | 1 |
2 other study(ies) available for lactic acid and ribosomal protein l7-l12
| Article | Year |
|---|---|
Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection.
Topics: Animals; Antibodies, Bacterial; Brucella abortus; Brucella Vaccine; Brucellosis; Enzyme-Linked Immunospot Assay; Female; Humans; Immunity, Cellular; Interferon-gamma; Lactic Acid; Mice, Inbred BALB C; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; Ribosomal Proteins; Spleen; Vaccines, Synthetic | 2015 |
PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Bacterial; Antigens, Bacterial; Brucella abortus; Brucella Vaccine; Brucellosis; Colony Count, Microbial; Drug Delivery Systems; Escherichia coli; Female; Gene Expression; Immunity, Cellular; Immunity, Humoral; Immunization, Secondary; Immunoglobulin G; Lactic Acid; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; Ribosomal Proteins; Spleen | 2015 |